Financial Ratios

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3436.7572 (+2.14 %)
PREV CLOSE ( ) 3364.75
OPEN PRICE ( ) 3366.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 69822
TODAY'S LOW / HIGH ( )3366.00 3469.50
52 WK LOW / HIGH ( )2776 4072.35
NSE3445.3077.45 (+2.3 %)
PREV CLOSE( ) 3367.85
OPEN PRICE ( ) 3367.05
BID PRICE (QTY) 3445.30 (696)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1145370
TODAY'S LOW / HIGH( ) 3367.05 3469.70
52 WK LOW / HIGH ( )2775 4074.4
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)68.12111.0873.6451.7150.20
   CEPS(Rs)81.00122.7883.2358.7256.56
   DPS(Rs)30.0030.0020.0016.0016.00
   Book NAV/Share(Rs)478.64440.44349.28275.63262.70
   Tax Rate(%)23.1919.8025.6224.3027.31
Margin Ratios
   Core EBITDA Margin(%)30.6043.4241.3633.8337.60
   EBIT Margin(%)30.6941.2238.5633.9137.35
   Pre Tax Margin(%)30.6641.2038.5333.7737.26
   PAT Margin (%)23.5533.0428.6625.5727.08
   Cash Profit Margin (%)28.0136.5232.3929.0330.52
Performance Ratios
   ROA(%)12.3222.7618.8415.0815.52
   ROE(%)14.8228.1323.5719.2120.61
   ROCE(%)19.3135.0931.6425.2328.06
   Asset Turnover(x)0.520.690.660.590.57
   Sales/Fixed Asset(x)1.281.731.661.751.97
   Working Capital/Sales(x)0.941.251.351.431.29
Efficiency Ratios
   Fixed Capital/Sales(x)0.780.580.600.570.51
   Receivable days107.7988.2687.7395.7088.81
   Inventory Days128.9595.85101.33115.82109.22
   Payable days91.2092.79107.0792.9488.28
Valuation Parameters
   PER(x)41.4839.6549.3038.4333.93
   PCE(x)34.8835.8743.6133.8530.11
   Price/Book(x)5.9010.0010.397.216.48
   Yield(%)1.060.680.550.810.94
   EV/Net Sales(x)9.2912.8513.869.929.27
   EV/Core EBITDA(x)26.2528.6032.6726.2622.53
   EV/EBIT(x)30.0631.0235.8328.9424.60
   EV/CE(x)4.797.838.315.605.14
   M Cap / Sales9.8413.1614.179.939.27
Growth Ratio
   Net Sales Growth(%)-14.1330.6128.028.8327.88
   Core EBITDA Growth(%)-32.3638.2943.77-0.0247.11
   EBIT Growth(%)-35.9539.8744.46-0.9550.44
   PAT Growth(%)-38.6850.8442.403.0153.25
   EPS Growth(%)-38.6850.8442.403.0153.25
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.02
   Current Ratio(x)6.403.943.953.095.58
   Quick Ratio(x)4.562.852.762.123.58
   Interest Cover(x)1393.962126.161452.86258.94398.66
   Total Debt/Mcap(x)0.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.